Local Phone: 0845 260 2602
Title21 Health Solutions, a portfolio company specialising in life science regulatory support, has joined the Blood and Cells Advocacy...
Read MoreSobi has entered into an agreement to acquire Arthrosi Therapeutics, a private late-stage biotechnology company focused on developing a...
Read MoreLindus Health and Quotient Sciences have announced a strategic partnership designed to enable enhanced patient recruitment and create more...
Read MoreMRM Health, a clinical-stage biopharmaceutical company developing microbiome-based therapeutics for inflammatory diseases and immuno-oncology, has announced a collaboration with...
Read MoreGRI Bio has announced positive topline results from its phase 2a clinical trial evaluating GRI-0621 in idiopathic pulmonary fibrosis...
Read MoreJohnson & Johnson has reported what it describes as unprecedented phase 3 results from the MajesTEC-3 study, positioning TECVAYLI...
Read More
